Claritev Profit Margin 2019-2025 | CTEV
Current and historical gross margin, operating margin and net profit margin for Claritev (CTEV) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Claritev net profit margin as of March 31, 2025 is -126.96%.
| Claritev Annual Profit Margins |
|---|
| Claritev Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.682B | $0.931B |
| Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.804B | 58.27 |
| Tempus AI (TEM) | United States | $11.365B | 0.00 |
| Doximity (DOCS) | United States | $10.890B | 50.42 |
| Hims & Hers Health (HIMS) | United States | $9.396B | 97.63 |
| IRhythm Technologies (IRTC) | United States | $4.819B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.834B | 59.90 |
| Hinge Health (HNGE) | United States | $3.409B | 0.00 |
| Privia Health (PRVA) | United States | $2.635B | 180.08 |
| Enovis (ENOV) | United States | $1.711B | 9.54 |
| Phreesia (PHR) | United States | $1.608B | 0.00 |
| Schrodinger (SDGR) | United States | $1.493B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.440B | 0.00 |
| Azenta (AZTA) | United States | $1.334B | 61.98 |
| Omnicell (OMCL) | United States | $1.329B | 23.45 |
| 10x Genomics (TXG) | United States | $1.329B | 0.00 |
| Evolent Health (EVH) | United States | $1.233B | 105.00 |
| Fulgent Genetics (FLGT) | United States | $0.588B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.507B | 0.00 |
| Veradigm (MDRX) | United States | $0.486B | 0.00 |
| Standard BioTools (LAB) | United States | $0.467B | 0.00 |
| Talkspace (TALK) | United States | $0.462B | 138.00 |
| TruBridge (TBRG) | United States | $0.337B | 748.33 |
| Outset Medical (OM) | United States | $0.308B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.158B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.133B | 0.00 |
| CareCloud (CCLD) | United States | $0.105B | 4.02 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| Pulmonx (LUNG) | United States | $0.103B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.050B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.044B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |